Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration today announced it has granted Emergency Use Authorization to a PCR-based assay developed by the US Centers for Disease Control and Prevention to detect Zika virus.

The Trioplex Real-time RT-PCR Assay tests patient samples for chikungunya, dengue, and Zika viruses in a single test. Symptoms of Zika, chikungunya, and dengue infection are similar and a PCR-based assay may be advantageous for early detection and because immunoassays reportedly tend to show cross-reactivity between these pathogens.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Oregon state Senate unanimously passed a bill that would make it easier for people convicted of crimes to initiate DNA testing of evidence, according to the Associated Press.

People reports that researchers have uncovered genetic variants that lead people to always feel full.

Florida state senators are to weigh a bill prohibiting life insurance companies from using genetic information in coverage decisions, according to Florida Politics.

In Genome Research this week: metagenomic sequencing assay that detects pathogens in cerebrospinal fluid, single-tube long fragment read approach, and more.

May
08
Sponsored by
Sysmex Inostics

This webinar will present recent evidence that demonstrates how incorporating circulating tumor DNA (ctDNA) assessments into real-world patient management can influence patient care decisions, alter radiographic interpretations, and impact clinical outcomes.

May
22
Sponsored by
Stilla

This webinar will outline the entire liquid biopsy workflow from cell-free DNA isolation to mutation detection by Crystal Digital PCR with the Naica System from Stilla Technologies.